Loading organizations...
Based in Somerville, Massachusetts, Aitia develops causal artificial intelligence and computational digital twin technology to accelerate drug discovery and research for the global pharmaceutical industry. The company utilizes advanced machine learning software platforms to simulate complex disease progression and patient responses, focusing its therapeutic efforts primarily on neurodegenerative conditions and oncology. Operating through strategic co-discovery partnerships and proprietary pipeline development, the firm identifies novel therapeutic targets and optimizes clinical trials prior to the investigational new drug stage. Aitia has raised over $80 million in total venture capital funding to support its operations and has established strategic partnerships with major biopharmaceutical organizations including UCB, Servier, Charles River Laboratories, and Amgen Ventures. Originally established as a technology provider under the name GNS Healthcare before officially rebranding in January 2023, the enterprise was founded in 2000 by Colin Hill and Iya Khalil.
Aitia has raised $49.0M across 4 funding rounds.
Aitia has raised $49.0M in total across 4 funding rounds.
Aitia has raised $49.0M across 4 funding rounds. Most recently, it raised $23.0M Series D in July 2019.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Jul 9, 2019 | $23M Series D | TOM Richards | Gary Loveman, Alexandria Venture Investments, Amgen Ventures, Celgene, Echo Health Ventures | Announced |
| Aug 23, 2017 | $6M Venture Round | Amgen Ventures | Alexandria Venture Investments | Announced |
| Dec 8, 2015 | $10M Series C | — | Alexandria Venture Investments, California, Cambia Health Solutions, Celgene, Dennis Gillings, Heritage Provider Network | Announced |
| Jan 29, 2014 | $10M Series B | — | Mark Ganz, Richard Merkin, Masahiro Moriyasu | Announced |
Aitia has raised $49.0M in total across 4 funding rounds.
Aitia's investors include Tom Richards, Gary Loveman, Alexandria Venture Investments, Amgen Ventures, Celgene, Echo Health Ventures, California, Cambia Health Solutions, Dennis Gillings, Heritage Provider Network, Mark Ganz, Richard Merkin.